Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

NCT05044273 · tracked via the Priya Life Science South Korea tracker

Sponsor

Jung-min Ahn

Phase

Observational

Started

2022-09-01

Last updated

2025-12-29

Condition(s) studied

Coronary Artery DiseaseCardiovascular DiseasesHeart DiseasesMyocardial IschemiaCoronary Disease

Investigational drug(s) / intervention(s)

Synergy XD stent or Synergy Megatron™ Stent

Synergy XD stent or Synergy Megatron™ Stent: Percutaneous coronary intervention with Synergy XD stent or Synergy Megatron™ Stent

Study summary

The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.

Eligibility

Sex

ALL

Min age

19 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients ≥ 19 years old * Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s). * The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: * Patients with a mixture of other drug-eluting stents (DESs) * Terminal illness with life-expectancy ≤1 year. * Patients with cardiogenic shock

Primary outcome measure(s)

The composite event rate of death, non-fatal myocardial infarction, or target vessel revascularization — 1 year
A composite endpoint is an endpoint that is a combination of multiple clinical endpoints. An event that is considered to have occurred if any one of several different events is observed.

Trial sites (23)

Facility	City	Region	Status
Hallym University Medical Center	Anyang	South Korea	Recruiting
Dong-A University Hospital	Busan	South Korea	Recruiting
Inje University Busan Paik Hospital	Busan	South Korea	Terminated
Inje university Pusan Paik hospital	Busan	South Korea	Recruiting
Pusan National University Hospital	Busan	South Korea	Terminated
Pusan National University Hospital	Busan	South Korea	Recruiting
Pusan National University Yangsan Hospital	Busan	South Korea	Recruiting
Gyeongsang National University Changwon Hospital	Changwon	South Korea	Recruiting
Samsung Changwon Hospital	Changwon	South Korea	Recruiting
Keimyung University Dongsan Medical Center	Daegu	South Korea	Recruiting
Veterans Hospital	Daegu	South Korea	Recruiting
Yeungnam University Medical Center	Daegu	South Korea	Recruiting
Gangneung Asan Hospital	Gangneung	South Korea	Recruiting
Chonnam National University Hospital	Gwangju	South Korea	Recruiting
Wonkwang University Hospital	Iksan	South Korea	Recruiting
CHA Bundang Medical Center, CHA University	Seongnam	South Korea	Terminated
Seoul university Bundang hospital	Seongnam	South Korea	Recruiting
Asan Medical Center	Seoul	South Korea	Recruiting
Hanyang University Seoul Hospital	Seoul	South Korea	Recruiting
Korea University Anam Hospital	Seoul	South Korea	Recruiting
Korea University Guro Hospital	Seoul	South Korea	Terminated
The Catholic University of Korea, ST. Vincent's Hospital	Suwon	South Korea	Recruiting
Ulsan University Hospital	Ulsan	South Korea	Recruiting

More Jung-min Ahn trials in South Korea

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography Recruiting

IRIS-Synergy Cohort in the IRIS-DES Registry Active, not recruiting

Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers Starting soon

Other trials for the same condition

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease Active, not recruiting

Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study. Recruiting

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography Recruiting

Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry Starting soon

Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05044273 on ClinicalTrials.gov ↗ ← All trials in South Korea